Valneva SE is a vaccine company focused on developing life-saving vaccines... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VALN is expected to report earnings to fall 49.63% to -19 cents per share on November 12
Q3'26
Est.
$-0.20
Q2'26
Missed
by $0.18
Q1'26
Missed
by $0.24
Q4'25
Missed
by $0.32
Q3'25
Missed
by $0.17
The last earnings report on August 13 showed earnings per share of -39 cents, missing the estimate of -21 cents. With 16.45K shares outstanding, the current market capitalization sits at 636.51M.